FDA Commissioner Praises NTELX Solution

FDA Commissioner Praises NTELX Solution

 

Vienna, Va. – In testimony to the Oversight and Investigations Subcommittee of the US House of Representatives Committee on Energy and Commerce, the Food and Drug Administration Commissioner Dr. Margaret Hamburg praised PREDICT, a solution supported by NTELX’s technology and analytical expertise.

Using FDA industry-specific knowledge, NTELX developed predictive targeting techniques, allowing the FDA to screen each shipment electronically to determine whether it meets the threshold for physical inspection or sampling, allowing the FDA to target hazardous products more accurately. In field testing, PREDICT has proven itself to be more rapid and accurate than the previous system. PREDICT is currently in use in the New York, Los Angeles, Seattle, and San Francisco–FDA districts covering approximately 40% of total imports to the United States.

About NTELX

NTELX, headquartered in the Virginia suburbs outside Washington, DC, supports clients as they tackle complex operational decisions. With capabilities that support the decision management life-cycle from strategy to data analytics to solution design, implementation, and maintenance, and expertise in logistics, human services, and intelligence, NTELX has a proven track record of producing results. Our technology solutions are used by private and public sector organizations around the world to manage operations and business logistics. NTELX has delivered and supports critical solutions for the United States Government, including the Department of Defense, the Department of Homeland Security, and the Department of Health and Human Services.

About FDA

The Food and Drug Administration is the oldest comprehensive consumer protection agency in the US federal government. FDA’s modern regulatory functions began with the passage of the 1906 Pure Food and Drugs Act, a law a quarter-century in the making that prohibited interstate commerce in adulterated and mis-branded food and drugs.